Scholar Rock Holding Corp SEC filings SRRK
Scholar Rock Holding Corp has 649 filings in SEC EDGAR's recent list, going back to Jan 8, 2018. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 25, 2022 | — |
| CORRESP | Letter to the SEC | Nov 22, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2022 | — |
| EFFECT | Filing | Apr 13, 2022 | — |
| POSASR | Filing | Mar 7, 2022 | — |
| EFFECT | Filing | Jun 10, 2019 | — |
| CORRESP | Letter to the SEC | Jun 6, 2019 | — |
| CT ORDER | Filing | Jun 6, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2019 | — |
| CT ORDER | Filing | Mar 4, 2019 | — |
| CT ORDER | Filing | May 24, 2018 | — |
| EFFECT | Filing | May 23, 2018 | — |
| CERT | Filing | May 23, 2018 | — |
| 8-A12B | Filing | May 21, 2018 | — |
| CORRESP | Letter to the SEC | May 21, 2018 | — |
| CORRESP | Letter to the SEC | May 21, 2018 | — |
| CORRESP | Letter to the SEC | May 8, 2018 | — |
| UPLOAD | Letter from the SEC | May 4, 2018 | — |
| CORRESP | Letter to the SEC | May 3, 2018 | — |
| DRSLTR | Filing | Apr 25, 2018 | — |
| DRS/A | Filing | Apr 25, 2018 | — |
| DRS/A | Filing | Apr 20, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 19, 2018 | — |
| DRS | Filing | Mar 26, 2018 | — |
| D | Filing | Jan 8, 2018 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SRRK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1727196
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.